000			02298nam a2200481 i 4500
001			on1175662700
003			OCoLC
005			20200902124616.0
006			m o d f
007			cr |||||||||||
008			200717s2020 dcu o f000 0 eng c
024	8		_a30-486 _q(GPO jacket number)
040			_aGPO _beng _erda _epn _cGPO _dMvI
042			_apcc
043			_an-us---
050		4	_aKF26 _b.L27 2018u
074			_a1043-C (online)
086	0		_aY 4.L 11/4:S.HRG.115-820
099			_aY 4.L 11/4:S.HRG.115-820
110	1		_aUnited States. _bCongress. _bSenate. _bCommittee on Health, Education, Labor, and Pensions, _eauthor.
240	1	0	_aCost of prescription drugs (2018 June 12)
245	1	4	_aThe cost of prescription drugs : _bexamining the President's blueprint 'American Patients First' to lower drug prices : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining the cost of prescription drugs, focusing on examining the President's blueprint `American Patients First' to lower drug prices, June 12, 2018.
246	3		_aExamining the President's blueprint 'American Patients First' to lower drug prices
264		1	_aWashington : _bU.S. Government Publishing Office, _c2020.
300			_a1 online resource (iii, 41 pages).
336			_btxt
337			_bc _2rdamedia
338			_bcr _2rdacarrier
490	1		_aS. hrg. ; _v115-820
500			_aAccess ID (govinfo): CHRG-115shrg30486.
500			_aGPO Cataloging Record Distribution Program (CRDP).
511	0		_aHearing witnesses: Azar II, Hon. Alex M., Secretary, Department of Health and Human Services, Washington, DC.
518			_aDate of hearing: 2018-06-12.
588			_aDescription based on online resource; title from PDF title page (govinfo, viewed July 17, 2020).
650		0	_aDrugs _zUnited States _xCost control.
650		0	_aPharmaceutical policy _zUnited States.
650		0	_aPrescription pricing _zUnited States.
655		7	_aLegislative hearings. _2lcgft
810	1		_aUnited States. _bCongress. _bSenate. _tS. hrg. ; _v115-820.
856	4	0	_uhttps://purl.fdlp.gov/GPO/gpo141550
922			_aGOVINFOHRG
922			_aBIBCONEW _b20200717
999			_c294909 _d294909